Clinical Trials Browser

Phase 1 × tozuleristide × Dermatologic × Clear all

NCT02097875 2015-04-21

Safety Study of a Fluorescent Marker to Visualize Cancer Cells

Phase 1 Completed

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Melanoma, Skin Neoplasms